Clinical characteristics of myasthenia gravis patients with coexistence of AChR and titin antibodies
This study provides the first systematic characterization of the clinical profile of AChR-Ab<sup>+</sup>/Titin-Ab<sup>+</sup> myasthenia gravis patients in Southwest China. Our findings indicate that dual antibody-positive MG patients are more prone to generalized disease involvement and have a higher susceptibility to thyroid dysfunction.
Authors
- Xujun Chu (ORCID: https://orcid.org/0000-0002-6497-1979)
- Qi‐Jie Zhang (ORCID: https://orcid.org/0000-0002-1311-5582)
- Jianjian Bao
- Jia Liu (ORCID: https://orcid.org/0000-0002-2299-681X)
- Siqi Wang (ORCID: https://orcid.org/0000-0002-2709-3185)
- Qian Fang (ORCID: https://orcid.org/0000-0002-2573-1358)
- Yan Zheng (ORCID: https://orcid.org/0000-0003-0632-8798)
- Kang Du (ORCID: https://orcid.org/0000-0001-9947-2320)
- Shanshan Wu (ORCID: https://orcid.org/0000-0001-6417-8340)
- Difang Shi
- Weiwei Xiao
Institutions
- Kunming Medical University (CN)
- Qujing Normal University (CN)
- Shandong Provincial Hospital (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Frontiers in Neurology
- Published
- 2025-11-28
- DOI
- https://doi.org/10.3389/fneur.2025.1679404
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 0.00